• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用健康记录来描述美国一家人类服务机构中的肥胖、合并症和医疗服务情况。

Utilizing health records to characterize obesity, comorbidities, and health-care services in one human service agency in the United States.

作者信息

Fisher Kathleen, Hardie Thomas L, Ranjan Sobhana, Peterson Justin

机构信息

Drexel University, USA.

University of Pennsylvania, USA.

出版信息

J Intellect Disabil. 2017 Dec;21(4):387-400. doi: 10.1177/1744629516660417. Epub 2017 Feb 7.

DOI:10.1177/1744629516660417
PMID:27486185
Abstract

US surveys report higher prevalence of obesity in adults with intellectual disability. Health records of 40 adults with intellectual disability were retrospectively reviewed for data on health status, problem lists with International Classification of Diseases, Ninth Revision codes, medication lists, and health encounters over 18 months. Mean age was 49.5 years, 53% were males. Prevalence of overweight, obese, and morbidly obese was 28%, 58%, and 23%, respectively. Primary diagnosis was intellectual disability (50% mild, 33% moderate, 10% severe, and 8% profound), 85% had mental health disorders (67.5% with affective or mood and 42.5% had anxiety disorders). On average, residents consumed 2.63 psychotropic medications daily with additional 5.75 medications for axis 3 diagnoses and made 39.2 health visits over past 18 months. Our analysis supports increased prevalence of overweight/obesity, higher comorbidities, dual psychiatric diagnosis, substantial medication consumption, and higher utilization of health-care services in adults with intellectual disabilities. Targeted health interventions are therefore essential to improve their health and quality of life.

摘要

美国的调查显示,智障成年人中肥胖的患病率更高。我们回顾性分析了40名智障成年人的健康记录,以获取其健康状况、带有国际疾病分类第九版编码的问题清单、用药清单以及18个月内的医疗接触情况等数据。平均年龄为49.5岁,53%为男性。超重、肥胖和病态肥胖的患病率分别为28%、58%和23%。主要诊断为智力残疾(50%为轻度,33%为中度,10%为重度,8%为极重度),85%患有精神健康障碍(67.5%患有情感或情绪障碍,42.5%患有焦虑症)。居民平均每天服用2.63种精神药物,另外针对第三轴诊断还服用5.75种药物,在过去18个月内进行了39.2次医疗就诊。我们的分析支持了智障成年人中超重/肥胖患病率增加、合并症更多、双重精神诊断、大量用药以及更高的医疗服务利用率。因此,有针对性的健康干预对于改善他们的健康和生活质量至关重要。

相似文献

1
Utilizing health records to characterize obesity, comorbidities, and health-care services in one human service agency in the United States.利用健康记录来描述美国一家人类服务机构中的肥胖、合并症和医疗服务情况。
J Intellect Disabil. 2017 Dec;21(4):387-400. doi: 10.1177/1744629516660417. Epub 2017 Feb 7.
2
Overweight and obesity among adults with intellectual disabilities who use intellectual disability/developmental disability services in 20 U.S. States.20 个美国州中,使用智力残疾/发育障碍服务的成年智力残疾者中的超重和肥胖。
Am J Intellect Dev Disabil. 2011 Nov;116(6):401-18. doi: 10.1352/1944-7558-116.6.401.
3
Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.为智障人士及其他精神障碍患者开具精神药物处方。
Psychiatr Serv. 2014 Feb 1;65(2):201-7. doi: 10.1176/appi.ps.201300029.
4
The overweight: obesity and plasma lipids in adults with intellectual disability and mental illness.超重:智力残疾和精神疾病成年人中的肥胖和血浆脂质。
J Intellect Disabil Res. 2012 Sep;56(9):895-901. doi: 10.1111/j.1365-2788.2011.01468.x. Epub 2011 Aug 31.
5
Fibromyalgia and Obesity: The Association Between Body Mass Index and Disability, Depression, History of Abuse, Medications, and Comorbidities.纤维肌痛与肥胖:体重指数与残疾、抑郁、虐待史、药物治疗及合并症之间的关联
J Clin Rheumatol. 2015 Sep;21(6):289-95. doi: 10.1097/RHU.0000000000000278.
6
Use of obesity-related care by psychiatric patients.精神科患者的肥胖相关护理使用情况。
Psychiatr Serv. 2012 Mar;63(3):230-6. doi: 10.1176/appi.ps.201100221.
7
Prevalence and potential factors associated with overweight and obesity status in adults with intellectual developmental disorders.成年智力发育障碍者超重和肥胖状况的流行情况及相关潜在因素。
J Appl Res Intellect Disabil. 2018 Jan;31 Suppl 1:29-38. doi: 10.1111/jar.12370. Epub 2017 May 24.
8
Obesity and associated factors in adults with intellectual disability.成年智障者的肥胖及相关因素
J Intellect Disabil Res. 2014 Sep;58(9):851-63. doi: 10.1111/jir.12100. Epub 2013 Nov 20.
9
[Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].[轻度或中度智力残疾成年人使用精神药物的决定因素]
Nervenarzt. 2017 Nov;88(11):1273-1280. doi: 10.1007/s00115-016-0211-0.
10
Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.智力残疾者的精神疾病、挑战性行为及精神药物处方:基于英国人群的队列研究
BMJ. 2015 Sep 1;351:h4326. doi: 10.1136/bmj.h4326.

引用本文的文献

1
Impact of COVID-19: Nursing challenges to meeting the care needs of people with developmental disabilities.COVID-19 的影响:满足发展障碍人士护理需求的护理挑战。
Disabil Health J. 2021 Jan;14(1):101015. doi: 10.1016/j.dhjo.2020.101015. Epub 2020 Nov 4.
2
Feedback and Strategies From People With Intellectual Disability Completing a Personalized Online Weight Loss Intervention: A Qualitative Analysis.有智力障碍者完成个性化在线减肥干预后的反馈和策略:定性分析。
Intellect Dev Disabil. 2019 Dec;57(6):527-544. doi: 10.1352/1934-9556-57.6.527.
3
Niclosamide as an anti-obesity drug: an experimental study.
氯硝柳胺作为一种抗肥胖药物:一项实验研究。
Eat Weight Disord. 2017 Jun;22(2):339-344. doi: 10.1007/s40519-017-0373-1. Epub 2017 Mar 7.